Search Results 161-170 of 18325 for total bilirubin

  1. Phase 2 Study Of Ruxolitinib Versus Anagrelide In Subjects With Essential Thrombocythemia Who Are Resistant To Or Intolerant Of Hydroxyurea (RESET-272) - Mayo Clinic

    Total bilirubin > 1.5 × upper limit of normal (ULN); Aspartate aminotransferase or alanine aminotransferase > 1.5 × ULN; Hepatocellular disease (eg, cirrhosis).

  2. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients - Mayo Clinic

    Hepatic. Total bilirubin | ≤.5 × ULN OR direct bilirubin ≤LN for participants with total bilirubin levels >1.5 × ULN; AST (SGOT) and ALT (SGPT) | Part 1 ...

  3. A Trial To Evaluate The Efficacy And Safety Of Reldesemtiv In Patients With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Total bilirubin (TBL), direct or indirect bilirubin above the ULN. Cognitive impairment, related to ALS or otherwise that impairs the patient's ability to ...

  4. A Study Of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy For Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

    Total bilirubin ≤.5 ×ULN OR direct bilirubin ≤LN for participants with total bilirubin levels >1.5 × ULN; AST (SGOT) and ALT (SGPT) ≤.5 × ULN (≤ × ULN ...

  5. Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With A Safety Lead-in Of Encorafenib + Binimetinib + Cetuximab In Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    Serum total bilirubin ≤1.5 × ULN and < 2 mg/dL;. Note: Patients who have a total bilirubin level > 1.5 × ULN will be allowed if their indirect bilirubin ...

  6. Tumor Treating Fields For The Treatment Of Leptomeningeal Metastases Of The Spine In Patients With Breast Or Lung Cancer - Mayo Clinic

    ... total bilirubin is due to elevated indirect bilirubin from known Gilbert's disease, aspartate aminotransferase (AST) =\< 3.5 times upper limits of normal ...

  7. A Study To Evaluate Patisiran In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) - Mayo Clinic

    Total bilirubin ˃ULN. Patients with elevated total bilirubin that is secondary to documented Gilbert's syndrome are eligible if total bilirubin <2 × ULN ...

  8. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Total bilirubin ≤1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be &le 2.0 mg/dL; Measurable disease ...

  9. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor - Mayo Clinic

    Total serum bilirubin ≤1.5 × ULN, with the following exception: Patients with previously documented Gilbert syndrome who may have a bilirubin <5 × ULN.

  10. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of HPN217 In Patients With Relaped/Refractory Multiple Myeloma - Mayo Clinic

    Total bilirubin ≤ 1.5 × upper limit of normal (ULN), regardless of direct bilirubin;; AST and ALT ≤ 3.0 × ULN (≤ 5.0× ULN if due to myeloma involvement); ...